A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy.

PURPOSE The 3 tumor locations unsampled by conventional sextant biopsies that have been identified on composite 3-dimensional reconstruction of 180 radical prostatectomy specimens are the anterior transition zone, midline peripheral zone and inferior portions of the anterior horn in the peripheral zone. We evaluated an 11-core multisite directed biopsy scheme incorporating these alternate areas and conventional sextant biopsies in 362 patients from 2 institutions. MATERIALS AND METHODS Patients without a prior diagnosis of cancer underwent ultrasound guided 11-core biopsies which included conventional sextant and 3 alternate sites. All specimens were separated for specific location identification. Biopsy was performed in 183 patients at MD Anderson Cancer Center (group 1) and in 179 at Toronto General Hospital (group 2). All group 2 and 54% of group 1 patients (98 of 183) had a prior biopsy negative for cancer. RESULTS Median prostate specific antigen was higher in group 2 than in group 1 patients (11.5 versus 9.5 ng./ml., p = 0.016). Overall a 33% increase (36 of 110 patients) in cancer detection was observed when biopsy technique included the alternate areas (p = 0.0021). The anterior horn was the most frequently positive biopsy site followed by the transition zone and midline sites. The 11-core technique had significantly better cancer detection rates when digital rectal examination and transrectal ultrasound were normal, and in men with serum prostate specific antigen between 4.1 and 10 ng./ml. CONCLUSIONS Biopsies of the alternate sites suggested by our simulation studies are feasible and reproducible. This new strategy significantly enhanced (p = 0.0075) prostate cancer detection compared to conventional sextant biopsies in men undergoing a repeat procedure.

[1]  L. Bégin,et al.  Value of systematic transition zone biopsies in the early detection of prostate cancer. , 1996, The Journal of urology.

[2]  C. Roehrborn,et al.  Diagnostic yield of repeated transrectal ultrasound-guided biopsies stratified by specific histopathologic diagnoses and prostate specific antigen levels. , 1996, Urology.

[3]  J. McNeal,et al.  Limitations of transition zone needle biopsy findings in the prediction of transition zone cancer and tissue composition of benign nodular hyperplasia. , 1996, Urology.

[4]  C. Smart,et al.  The fall in incidence of prostate carcinoma: On the down side of a prostate specific antigen induced peak in incidence‐‐Data from the Utah Cancer Registry , 1996, Cancer.

[5]  R. Kane,et al.  American cancer society–national prostate cancer detection project. Results from multiple examinations using transrectal ultrasound, digital rectal examination, and prostate specific antigen , 1993, Cancer.

[6]  D. Johnston,et al.  Comparison of prostate biopsy schemes by computer simulation. , 1999, Urology.

[7]  M. Terris,et al.  Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. , 1989, The Journal of urology.

[8]  T. Stamey,et al.  Making the most out of six systematic sextant biopsies. , 1995, Urology.

[9]  C. Dinney,et al.  Diagnostic testing for prostate cancer detection: less is best. , 1993, Urology.

[10]  L. Chang,et al.  Participation of paraventricular nucleus of hypothalamus in central regulation of penile erection in the rat. , 1997, The Journal of urology.

[11]  D. Johnston,et al.  Optimization of prostate biopsy strategy using computer based analysis. , 1997, The Journal of urology.

[12]  Experience with vasal sperm aspiration. , 1998, The Journal of urology.

[13]  W. Fair,et al.  Indications for transition zone biopsy in the detection of prostatic carcinoma. , 1997, The Journal of urology.

[14]  T. Stamey,et al.  Large, organ confined, impalpable transition zone prostate cancer: association with metastatic levels of prostate specific antigen. , 1993, The Journal of urology.

[15]  W. Catalona,et al.  Prostatic transition zone biopsies in men with previous negative biopsies and persistently elevated serum prostate specific antigen values. , 1995, The Journal of urology.

[16]  W. Fair,et al.  Incidence and clinical significance of false-negative sextant prostate biopsies. , 1998, The Journal of urology.

[17]  T. J. Breen,et al.  Biostatistical Analysis (2nd ed.). , 1986 .

[18]  R. Babaian,et al.  Role of PSA and its indices in determining the need for repeat prostate biopsies. , 1997, Urology.

[19]  J. Melamed,et al.  Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. , 1998, The Journal of urology.

[20]  D L McCullough,et al.  Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. , 1997, The Journal of urology.

[21]  Taylor Murray,et al.  Cancer statistics, 1999 , 1999, CA: a cancer journal for clinicians.

[22]  W. Catalona,et al.  Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. , 1991, The New England journal of medicine.

[23]  W. Cooner,et al.  Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. , 1990, The Journal of urology.